Tag Archives: Parkinson’s disease

H. Lundbeck A/S initiates a phase I study of a potential new treatment of Parkinson’s disease

Lu AF28996 is the third compound added to Lundbeck’s clinical development pipeline in 2018. VALBY, 28-Jun-2018 — /EuropaWire/ — H. Lundbeck A/S (Lundbeck) again expands its pipeline of clinical development projects with the initiation of a phase I study of a … Read the full press release

Excess levels of calcium in brain cells may lead to the formation of toxic clusters that are the hallmark of Parkinson’s disease

Researchers have found that excess levels of calcium in brain cells may lead to the formation of toxic clusters that are the hallmark of Parkinson’s disease. CAMBRIDGE, 20-Feb-2018 — /EuropaWire/ — The international team, led by the University of Cambridge, found … Read the full press release

Royal Philips to acquire US-based medical device company Electrical Geodesics, Inc.

AMSTERDAM, 22-Jun-2017 — /EuropaWire/ — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced an agreement to acquire Electrical Geodesics, Inc. (EGI), a US-based medical device company that designs, develops and commercializes a range of non-invasive … Read the full press release

Trinity College Dublin scientists made important breakthrough that generates new perspective on how nerve cells die in Parkinson’s disease

DUBLIN, 18-11-2014 — /EuropaWire/ — Scientists at Trinity College Dublin have made an important breakthrough in our understanding of Parkin – a protein that regulates the repair and replacement of nerve cells within the brain. This breakthrough generates a new … Read the full press release

Newcastle University researchers found link between gait and dementia

Newcastle, UK, 27-10-2014 — /EuropaWire/ — Researchers at Newcastle University have found a definitive link between gait – the way someone walks – and early changes in cognitive function in people with Parkinson’s disease. And the findings, published today (22nd October … Read the full press release

Biotie Therapies Corp. released its H1-2013 interim report

19-8-2013 — /EuropaWire/ — Company Highlights April – June 2013 Biotie obtained an exclusive option to acquire Neurelis, Inc., a private specialty pharmaceutical company based in San Diego, CA, focused on developing products for epilepsy and other disorders of the central nervous … Read the full press release

University of Cambridge, University of Sheffield and University College London researchers link genetic mutations to Parkinson’s disease

15-8-2013 — /EuropaWire/ — Researchers have discovered how genetic mutations linked to Parkinson’s disease might play a key role in the death of brain cells, potentially paving the way for the development of more effective drug treatments. In the new study, … Read the full press release